-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Deferiprone in Amyotrophic Lateral Sclerosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Deferiprone in Amyotrophic Lateral Sclerosis report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Deferiprone in Amyotrophic Lateral Sclerosis Drug Details: Deferiprone (Ferriprox) is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – JAB-3312 in Pancreatic Ductal Carcinoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - JAB-3312 in Pancreatic Ductal Carcinoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. JAB-3312 in Pancreatic Ductal Carcinoma Drug Details: JAB-3312 is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – TransCon IL-2 Beta/Gamma in Renal Cell Carcinoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - TransCon IL-2 Beta/Gamma in Renal Cell Carcinoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. TransCon IL-2 Beta/Gamma in Renal Cell Carcinoma Drug...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SOF-10 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - SOF-10 in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. SOF-10 in Solid Tumor Drug Details: SOF-10 (RG6440) is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – JNJ-2113 in Ulcerative Colitis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - JNJ-2113 in Ulcerative Colitis report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. JNJ-2113 in Ulcerative Colitis Drug Details: JNJ-2113 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Seltorexant in Alzheimer’s Disease
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Seltorexant in Alzheimer's Disease report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Seltorexant in Alzheimer's Disease Drug Details: Seltorexant (JNJ-7922, JNJ-42847922, MIN-202) is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Emactuzumab in Adenocarcinoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Emactuzumab in Adenocarcinoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Emactuzumab in Adenocarcinoma Drug Details: Emactuzumab (RG-7155, RO5509554) is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – KITE-222 in Diffuse Large B-Cell Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - KITE-222 in Diffuse Large B-Cell Lymphoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. KITE-222 in Diffuse Large B-Cell Lymphoma Drug Details: KITE-222...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SC-291 in Mantle Cell Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - SC-291 in Mantle Cell Lymphoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. SC-291 in Mantle Cell Lymphoma Drug Details: SC-291 is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – LM-302 in Pancreatic Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - LM-302 in Pancreatic Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. LM-302 in Pancreatic Cancer Drug Details: LM-302 is under development for...